Rapamycin conditioning of dendritic cells differentiated from human ES cells promotes a tolerogenic phenotype.
While human embryonic stem cells (hESCs) may one day facilitate the treatment of degenerative diseases requiring cell replacement therapy, the success of regenerative medicine is predicated on overcoming the rejection of replacement tissues. Given the role played by dendritic cells (DCs) in the esta...
Autors principals: | Silk, K, Leishman, A, Nishimoto, K, Reddy, A, Fairchild, P |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2012
|
Ítems similars
-
Directed differentiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141+ subset
per: Sachamitr, P, et al.
Publicat: (2018) -
Differentiation of dendritic cells from human embryonic stem cells.
per: Silk, K, et al.
Publicat: (2011) -
Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141+ Subset
per: Patty Sachamitr, et al.
Publicat: (2018-01-01) -
Pharmacological manipulation of dendritic cells in the pursuit of transplantation tolerance.
per: Leishman, A, et al.
Publicat: (2011) -
Tolerogenicity is not an absolute property of a dendritic cell.
per: Farquhar, C, et al.
Publicat: (2010)